glp-1 agonist cardiovascular outcomes Agonists in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Beyond GLP1: modulating multiple nutrient-stimulated
Description
In summary, the DPP-4 inhibitors have demonstrated cardiovascular safety in multiple studies
Shavnya, and L
Discussion Major findings Our MR analysis demonstrated that genetically proxied GLP-1RAs are causally associated with a reduced risk of AF, cardiac arrest, and ventricular fibrillation
Median time (T max ) to maximal concentration (C max ) values ranged from 2.0 to 6.0 hours post-dose
15.Mullassaril P, Brodkin L, Brodkin J
Low glycaemic index or low glycaemic load diets for overweight and obesity
